腹腔镜直肠癌前切除术后吻合口漏及其影响因素分析

Incidence and influencing factors of anastomotic leakage after laparoscopic anterior resection for rectal cancer

  • 摘要:
    目的 探讨腹腔镜直肠癌前切除术后吻合口漏及其影响因素。
    方法 采用回顾性病例对照研究方法。收集2017年1月至2019年12月中国医学科学院北京协和医院收治的804例直肠癌患者的临床病理资料;男521例,女283例;年龄为63(27~94)岁。804例患者均行腹腔镜直肠癌前切除术。观察指标:(1)手术情况。(2)术后发生吻合口漏情况。(3)随访情况。(4)术后发生吻合口漏的影响因素分析。(5)亚组分析。正态分布的计量资料以x±s表示,组间比较采用独立样本t检验;偏态分布的计量资料以M(范围)表示,组间比较采用Mann‑Whitney U检验。计数资料以绝对数或百分比表示,组间比较采用χ2检验或Fisher确切概率法。单因素分析采用χ2检验或独立样本t检验。将单因素分析中P≤0.2的因素纳入多因素Logistic回归分析。
    结果 (1)手术情况。804例患者顺利完成腹腔镜中上段直肠癌根治性切除术,手术时间为135(118~256)min,术中出血量为30(5~350)mL。所有患者完成结肠‑直肠端端吻合。804例患者中,287例吻合口行加固缝合,517例吻合口行常规吻合。(2)术后发生吻合口漏情况。804例患者中,40例术后发生吻合口漏,发生率为4.98%(40/804)。(3)随访情况。804例患者均获得随访,随访时间为32(6~49)个月。无围手术期死亡患者。(4)术后发生吻合口漏的影响因素分析。多因素分析结果显示:吻合口不加固缝合是术后发生吻合口漏的独立危险因素(优势比=2.78,95%可信区间为1.21~6.37,P<0.05)。(5)亚组分析。804例患者中,202例接受新辅助治疗,602例未接受新辅助治疗。602未接受新辅助治疗患者中,253例加固缝合和349例常规吻合患者术后发生吻合口漏分别为6例和21例,两者比较,差异有统计学意义(χ²=4.56,P<0.05)。
    结论 吻合口不加固缝合是腹腔镜直肠癌前切除术后吻合口漏的独立危险因素,尤其对于未接受新辅助治疗的直肠癌患者。

     

    Abstract:
    Objective To investigate the incidence and influencing factors of anastomotic leakage after laparoscopic anterior resection for rectal cancer.
    Methods The retrospective case-control study was conducted. The clinicopathological data of 804 patients with rectal cancer who were admitted to Peking Union Medical College Hospital of Chinese Academy of Medical Sciences from January 2017 to December 2019 were collected. There were 521 male and 283 female, aged 63(range, 27-94)years. All 804 patients underwent laparoscopic anterior resection for rectal cancer. Observation indicators: (1) surgical situations; (2) incidence of postoperative anastomotic leakage; (3) follow-up; (4) influencing factors of postoperative anastomotic leakage; (5) subgroup analysis. Measurement data with normal distribution were represented as Mean±SD, and comparison between groups was conducted using the independent sample t test. Measurement data with skewed distribu-tion were represented as M(range), and comparison between groups was conducted using the Mann-Whitney U test. Count data were described as absolute numbers or percentages, and comparison between groups was conducted using the chi-square test or Fisher exact probability. Univariate analysis was conducted using the chi-square test or independent sample t test. Factors with P≤0.2 in univariate analysis were included in multivariate Logistic regression analysis.
    Results (1) Surgical situations. All 804 patients underwent laparoscopic radical resection of upper and middle rectal cancer successfully, with the operation time and volume of intraoperative blood loss as 135(range, 118-256)minutes and 30(range, 5-350)mL. All 804 patients completed end-to-end colon rectal anastomosis, including 287 patients with reinforced sutures at the anastomotic site, and 517 patients with routine anastomosis. (2) Incidence of postoperative anastomotic leakage. Of the 804 patients, 40 patients had postoperative anastomotic leakage, with the incidence rate as 4.98%(40/804). (3) Follow-up. All 804 patients were followed up for 32(range, 6-49)months. None of patient died during the perioperative period. (4) Influencing factors of postoperative anastomotic leakage. Results of multivariate analysis showed that unreinforced suture at the anastomotic site was an independent risk factor for postoperative anastomotic leakage (odds ratio=2.78, 95% confidence interval as 1.21-6.37, P<0.05). (5) Subgroup analysis. Of the 804 patients, 202 patients received neoadjuvant therapy and 602 patients did not receive neoadjuvant therapy. Of the 602 patients who did not receive neo-adjuvant therapy, cases with postoperative anastomotic leakage was 6 in the 253 patients with reinforced sutures, versus 21 in the 349 patients with routine sutures, showing a significant difference between them (χ2=4.56, P<0.05).
    Conclusion Unreinforced anastomosis at the anasto-motic site is an independent risk factor for anastomotic leakage after laparoscopic anterior rectal resection, especially for rectal cancer patients without neoadjuvant radiochemotherapy.

     

/

返回文章
返回